West Pharmaceutical Services, Inc. Free Cash Flow 2008–2025
West Pharmaceutical Services, Inc. reported $468.90M of free cash flow for fiscal 2025. That was 69.6% higher than fiscal 2024. Compared with fiscal 2020, the change was +57.3%.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $468.90M | +69.6% |
| FY 2024 | $276.40M | -33.3% |
| FY 2023 | $414.50M | -5.7% |
| FY 2022 | $439.40M | +32.9% |
| FY 2021 | $330.60M | +10.9% |
| FY 2020 | $298.10M | +23.8% |
| FY 2019 | $240.80M | +30.9% |
| FY 2018 | $183.90M | +38.8% |
| FY 2017 | $132.50M | +169.3% |
| FY 2016 | $49.20M | -39.1% |
| FY 2015 | $80.80M | +13.8% |
| FY 2014 | $71.00M | +3.5% |
| FY 2013 | $68.60M | +22.3% |
| FY 2012 | $56.10M | +58.9% |
| FY 2011 | $35.30M | -47.5% |
| FY 2010 | $67.20M | +104.9% |
| FY 2009 | $32.80M | +1011.1% |
| FY 2008 | $-3.60M | — |
Source: West Pharmaceutical Services, Inc. SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open WST 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
West Pharmaceutical Services, Inc. reported $468.90M of free cash flow for fiscal 2025. That was 69.6% higher than fiscal 2024. Compared with fiscal 2020, the change was +57.3%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for West Pharmaceutical Services, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeWest Pharmaceutical Services, Inc. — frequently asked questions
What is West Pharmaceutical Services, Inc.'s free cash flow?
West Pharmaceutical Services, Inc. (WST) reported free cash flow of $468.90M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from West Pharmaceutical Services, Inc.'s official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.